ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $45,144,000 | +30.4% | 2,393,612 | -18.6% | 17.24% | +51.8% |
| Q2 2019 | $34,629,000 | -13.8% | 2,942,130 | 0.0% | 11.36% | +8.6% |
| Q1 2019 | $40,160,000 | +33.2% | 2,942,130 | 0.0% | 10.45% | +5.5% |
| Q4 2018 | $30,157,000 | -38.4% | 2,942,130 | 0.0% | 9.90% | -8.4% |
| Q3 2018 | $48,986,000 | +5.4% | 2,942,130 | 0.0% | 10.81% | +8.0% |
| Q2 2018 | $46,486,000 | +24.4% | 2,942,130 | 0.0% | 10.01% | +22.9% |
| Q1 2018 | $37,365,000 | +14.6% | 2,942,130 | +3.3% | 8.14% | -11.0% |
| Q4 2017 | $32,600,000 | -9.5% | 2,847,130 | -3.2% | 9.15% | -7.9% |
| Q3 2017 | $36,042,000 | +44.6% | 2,942,203 | +35.1% | 9.93% | +21.9% |
| Q2 2017 | $24,929,000 | -26.4% | 2,177,203 | +33.6% | 8.14% | -37.4% |
| Q1 2017 | $33,888,000 | +0.1% | 1,629,222 | +0.1% | 13.01% | -11.6% |
| Q4 2016 | $33,869,000 | -34.8% | 1,628,328 | +2.7% | 14.72% | -39.4% |
| Q3 2016 | $51,963,000 | +30.0% | 1,585,683 | -0.9% | 24.29% | -11.4% |
| Q2 2016 | $39,957,000 | +27.6% | 1,600,183 | +25.2% | 27.42% | +13.2% |
| Q1 2016 | $31,312,000 | +312.4% | 1,278,570 | +456.2% | 24.23% | +259.8% |
| Q4 2015 | $7,593,000 | – | 229,895 | – | 6.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |